Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Aberrant DNA Methylation in Dimethylarsinic Acid-induced Rat Bladder Carcinogenesis

ABSTRACT: Aberrant DNA Methylation in Dimethylarsinic Acid-induced Rat Bladder Carcinogenesis

PROVIDER: PRJNA1017900 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Aberrant DNA Methylation in Dimethylarsinic Acid-induced Rat Bladder Carcinogenesis

Project description:DNA methylation profile in rat bladder carcinogenesis treated with dimethylarsinic acid.

2023-11-06 | GSE243372 | GEO

Urinary bladder in F344 rats: Control vs dimethylarsinic acid

Project description:The gene expression profling between Control and dimethylarsinic acid for 4 weeks in urinary bladder epithelium of F344 male rats.

2023-08-09 | GSE207963 | GEO

Urinary bladder in F344 rats: Control vs dimethylarsinic acid-induced tumors

Project description:The gene expression profling between non-treated urinary bladder epithelium (Control) and dimethylarsinic acid-induced urinary bladder tumors of F344 male rats.

2023-08-09 | GSE207973 | GEO

Urinary bladder in F344 rats: Control vs dimethylarsinic acid

Project description:Urinary bladder in F344 rats: Control vs dimethylarsinic acid

| PRJNA857753 | ENA

DNA Methylation Aberrations in Dimethylarsinic Acid-Induced Bladder Carcinogenesis.

Project description:Arsenic is a known human urinary bladder carcinogen. While arsenic is known to cause aberrant DNA methylation, the mechanism of arsenic-triggered bladder carcinogenesis is not fully understood. The goal of this study was to identify aberrant DNA methylation in rat bladder urothelial carcinoma (UC) induced by dimethylarsinic acid (DMAV), a major organic metabolite of arsenic. We performed genome-wide DNA methylation and microarray gene expression analyses of DMAV-induced rat UCs and the urothelium of rats treated for 4 weeks with DMAV. We identified 40 genes that were both hypermethylated and downregulated in DMAV-induced rat UCs. Notably, four genes (CPXM1, OPCML, TBX20, and KCND3) also showed reduced expression in the bladder urothelium after 4 weeks of exposure to DMAV. We also found that CPXM1 is aberrantly methylated and downregulated in human bladder cancers and human bladder cancer cells. Genes with aberrant DNA methylation and downregulated expression in DMAV-exposed bladder urothelium and in DMAV-induced UCs in rats, suggest that these alterations occurred in the early stages of arsenic-induced bladder carcinogenesis. Further study to evaluate the functions of these genes will advance our understanding of the role of aberrant DNA methylation in arsenic bladder carcinogenesis, and will also facilitate the identification of new therapeutic targets for arsenic-related bladder cancers.

| S-EPMC10648661 | biostudies-literature

Urinary bladder in F344 rats: Control vs dimethylarsinic acid-induced tumors

Project description:Urinary bladder in F344 rats: Control vs dimethylarsinic acid-induced tumors

| PRJNA857810 | ENA

Lung in neonatal mice: Control vs transplacental treated with dimethylarsinic acid (DMA)

Project description:The gene expression profling between Control and transplacental treated with 200 ppm dimethylarsinic acid (DMA) for 10 days in lung of neonatal male mice.

2020-04-21 | GSE139086 | GEO

Lung in neonatal mice: Control vs. transplacental treated with dimethylarsinic acid (DMA)

Project description:ChIP-seq profiling by Histone H3K9me3 antibody between Control and transplacental treated with 200 ppm dimethylarsinic acid (DMA) for 10 days in lung of neonatal male mice.

2020-04-21 | GSE141086 | GEO

FGFR3-shRNA induced transcriptional changes in RT112 bladder cancer cells

Project description:Aberrant activation of FGFR3 via overexpression or mutation is a frequent feature of bladder cancer; however, its molecular and cellular consequences and functional relevance to carcinogenesis are not well understood. In this study with a bladder carcinoma cell line expressing inducible FGFR3 shRNAs, we sought to identiy transcriptional targets of FGFR3 and investigate their contribution to bladder cancer development.

2012-11-07 | GSE41035 | GEO

Loss of LPAR6 and CAB39L Dysregulate Basal to Luminal Urothelial Differentiation Program Contributing to Bladder Carcinogenesis

Project description:In vitro and in vivo studies including single cell sequencing showed that LPAR6 and CAB39L play a major role in regulating basal to luminal urothelial differentiation. Their loss of function contributed to bladder carcinogenesis by dysregulating urothelial differentiation program and sensitizing the urothelium to N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) induced cancers, which recapitulated luminal and basal subtypes of human bladder cancer.

2024-06-19 | GSE235455 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data